<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=380349912402896&amp;ev=PageView&amp;noscript=1">
Logo_Black Blue2
×

logo_white

the first and only
fda approved
light therapy for dry eyes

"I’m very grateful that I had the opportunity to invest in my practice and get the first and only FDA approved light therapy for dry eye management"
James Deom, OD
"In addition to being the first and only light therapy for dry eye management, the system is also easily upgradable to offer aesthetic services if my patients are interested in that."
Carly Rose, OD
Our practice has trusted Lumenis technology for nearly 6 years; they continue to demonstrate their dedication to eye care with state-of-the-art technology, safety, efficacy, marketing, and provider support
Kambiz Silani, OD
Optilight_01_mrgשקוף

Contact us

To find out more about how you can grow your practice with OptiLight

Contact a rep
×

DIFFERENTIATE YOUR
PRACTICE WITH
OptiLIGHT

  • The first and only FDA approved light therapy for dry eye management

  • Patented OPT™ technology for targeted, precise, and controlled treatment

  • Breaks the dry eye vicious cycle of inflammation, offering a multi-factorial treatment to a multi-factorial disease

  • Designed with every element thoughtfully tailored to fit the needs of dry eye patients and doctors

  • Elevates the dry eye practice with an easily integrated, seamless workflow

Optilight_01_mrgשקוף

DIFFERENTIATE YOUR
PRACTICE WITH
OptiLight

The first and only FDA approved light therapy for dry eye management
Patented OPT™ technology for targeted, precise, and controlled treatment
Breaks the dry eye vicious cycle of inflammation, offering a multi-factorial treatment to a multi-factorial disease
Designed with every element thoughtfully tailored to fit the needs of dry eye patients and doctors
Elevates the dry eye practice with an easily integrated, seamless workflow
Optilight_01_mrgשקוף

Over 40 clinical studies support the effectiveness
and safety of
OptiLIGHT

  • 2.7x

    Increase in tear break up time¹

  • 6.3x

    More expressible glands²

  • 2.5x

    Reduction in pro-inflammatory mediators³

Visible results
that last

Courtesy of Laura M. Periman, MD

WHAT'S IN
THE PlAYBOOK

  • icon-2-4

    Our complimentary enhanced marketing packages and support programs

  • icon-1-4

    Practical tips on how to easily integrate OptiLIGHT into your workflow

  • icon-3-4

    How adding dry eye services can be your next business opportunity
+
Download the free eBook